High Impact Evidence Across the Lifecycle
Every medical device ultimately exists to improve the lives of patients. Generating the right evidence—from early development through regulatory review, coverage, and post-market—is essential to ensuring innovative technologies reach the people who need them.
The High Impact Evidence Across the Lifecycle Pillar brings together regulators, clinicians, manufacturers, patients, payers, and evidence experts to explore collaborative approaches for generating meaningful, patient-centered evidence.
Advancing Evidence from Concept to Coverage
Whether you’re developing a novel technology, designing a clinical study, or generating evidence for regulatory and reimbursement decisions, this MDIC Innovators Forum Pillar explores the strategies shaping modern medical device evidence generation.
Attendees will gain insights into patient-centered approaches to evidence generation, innovations in clinical trial design and execution, Early Feasibility Study (EFS) best practices, regulatory expectations for clinical evidence, strategies that support payer and coverage decisions, and emerging technologies improving evidence generation.
Bring Your Expertise to the Forum Stage
For the High Impact Evidence Across the Lifecycle Forum Pillar, we are seeking session proposals that include—but are not limited to—the following themes:
- Patient-Centered Evidence
- AI and Clinical Trial Efficiency
- Clinical Trial Innovation
- Excellence in Early Feasibility Studies
- Evidence to Enhance the Coverage Journey
- Patient Preference Information (PPI) for Regulatory Strategy
Submission Details
Accepted presenters receive a complimentary registration to the Innovators Forum.
EARLY DECISION DEADLINE: August 7, 2026 | Questions? Info@MDIC.org
August 7, 2026
Early decision deadline
March 1–4, 2027
MDIC Innovators Forum in Hyattsville, Maryland
Generating Better Evidence
Patient-Centered
Generate evidence that reflects patient experiences, preferences, and outcomes.
Regulatory-Ready
Design evidence strategies that support efficient regulatory review and decision-making.
Coverage & Adoption
Strengthen the evidence needed to support reimbursement, clinician confidence, and patient access.